RAD51 and triple-negative breast carcinoma: Moustafa et al. [13] reported that the downstream effects of Emi1 downregulation that contribute to poly-adenosine diphosphate ribose polymerase inhibitor (PARPi) resistance are increasing the concentration of the RAD51 protein in triple-negative breast cancer (TNBC) cells.